Press Releases

Strong Revenue Growth Drives Financial Results Company Raises Fiscal 2021 Guidance Across all Key Metrics Highlights   Third quarter revenue increased 15.8% to $522.5 million, or 14.3% in constant currency   Core revenue grew 14.8% to $508.9 million for the quarter, or 13.2% in constant currency  
Nov 03, 2021
New Menu Capability Now Available on VISION and VISION MAX Analyzers Increases Confidence in Blood Transfusion-Related Test Results RARITAN, N.J. , Sept. 27, 2021 /PRNewswire/ --  Ortho Clinical Diagnostics  (NASDAQ: OCDX), one of the world's largest pure-play in vitro diagnostics (IVD) companies,
Sep 27, 2021
Displaying 1 - 10 of 121